1. Home
  2. DSY vs SNGX Comparison

DSY vs SNGX Comparison

Compare DSY & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DSY

Big Tree Cloud Holdings Limited Ordinary Shares

N/A

Current Price

$2.81

Market Cap

13.6M

Sector

N/A

ML Signal

N/A

Logo Soligenix Inc.

SNGX

Soligenix Inc.

N/A

Current Price

$1.21

Market Cap

12.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DSY
SNGX
Founded
2020
1987
Country
China
United States
Employees
20
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.6M
12.3M
IPO Year
2023
2006

Fundamental Metrics

Financial Performance
Metric
DSY
SNGX
Price
$2.81
$1.21
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
31.0K
112.9K
Earning Date
01-01-0001
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$119,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.48
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$1.02
52 Week High
$4.03
$6.23

Technical Indicators

Market Signals
Indicator
DSY
SNGX
Relative Strength Index (RSI) 60.21 46.70
Support Level $2.66 $1.11
Resistance Level $4.02 $1.22
Average True Range (ATR) 0.34 0.07
MACD -0.14 0.00
Stochastic Oscillator 28.78 30.00

Price Performance

Historical Comparison
DSY
SNGX

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, distribution, and sales of personal care products and other consumer goods. Operating under a consumer-to-manufacturer and merchant (C2M) model, the company integrates online and offline operations to enhance customer engagement, product innovation, and marketing efficiency. Specializing in feminine hygiene products such as sterilized feminine pads, menstrual pants, and related items, Big Tree Cloud leverages its platform to consolidate resources within China's personal care industry while building a consumer community that provides direct feedback and product insights.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: